Cargando…

Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin

Kallistatin is a unique serine proteinase inhibitor and heparin-binding protein. A previous study conducted by our group indicated that kallistatin has antiangiogenic and antitumoral activities. In the present study, we report that kallistatin specifically binds to membrane surface-expressed nucleol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiao-Ping, Wang, Xiao, Xie, Xiao-Lan, Zhang, Gao-Ping, Lv, Feng-Jiao, Weng, Wen-Ting, Qiu, Fei, Li, Zhao-Fa, Lin, Jun-Sheng, Diao, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788634/ https://www.ncbi.nlm.nih.gov/pubmed/29416766 http://dx.doi.org/10.18632/oncotarget.23346

Ejemplares similares

Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway
por: Liu, Xiaochen, et al.
Publicado: (2013)

Protection Effect of Kallistatin on Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Antioxidative Stress
por: Huang, Xiaoping, et al.
Publicado: (2014)

Kallistatin - the score beats the marker
por: Draikiwicz, Steven, et al.
Publicado: (2013)

Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)

Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017)

Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018)

Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells
por: Wang, Guoquan, et al.
Publicado: (2016)

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
por: Cheng, Zhiyun, et al.
Publicado: (2015)

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
por: Li, Jiaze, et al.
Publicado: (2016)

Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
por: Harris, Emily M., et al.
Publicado: (2018)

MicroRNA Profiling of Transgenic Mice with Myocardial Overexpression of Nucleolin
por: Lyu, Qing-Lan, et al.
Publicado: (2018)

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
por: Shiau, Ai-Li, et al.
Publicado: (2010)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
por: Muhammad, Fauziyya, et al.
Publicado: (2020)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022)

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022)

Plasma kallistatin in critically ill patients with severe sepsis and septic shock
por: Lin, Wei-Chieh, et al.
Publicado: (2017)

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
por: Zhu, Yuxuan, et al.
Publicado: (2019)

Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
por: Hovanessian, Ara G., et al.
Publicado: (2010)

Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis
por: Kirman, Dogan Can, et al.
Publicado: (2022)

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
por: Jenkins, Alicia J, et al.
Publicado: (2010)

Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
por: Li, Pengfei, et al.
Publicado: (2015)

Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion
por: Ma, Lina, et al.
Publicado: (2020)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities
por: Mastrangelo, Peter, et al.
Publicado: (2017)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Photodynamic therapy – hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
por: Plenagl, Nikola, et al.
Publicado: (2019)

The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
por: Zhou, Ling, et al.
Publicado: (2023)

Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands
por: Fujiki, Hirota, et al.
Publicado: (2014)

The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
por: Xu, Meng-Dan, et al.
Publicado: (2018)

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Binding of cellular nucleolin with the viral core RNA G-quadruplex structure suppresses HCV replication
por: Bian, Wen-Xiu, et al.
Publicado: (2019)

AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021)

Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
por: Chao, Julie, et al.
Publicado: (2018)

Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation
por: Yang, Yanhui, et al.
Publicado: (2020)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lc2smtjdt3t7bud3vibmjlbd3t